S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7125 +0.22%
PRE-MKT · 07:20 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

MYGN

MYRIAD GENETICS INC
NASDAQ · HEALTH CARE · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
5.57
+0.03 +0.54%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $532.8MP/E —DIV YIELD —FCF YIELD —REV TTM $806.6M −3.2%NET INCOME −$112.6MNET DEBT $5.5M52W 2.86 – 8.18SEC XBRL · TTM TO Invalid Date

What MYGN had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 20Material agreementReg FD disclosureOct 19open on EDGAR ↗
Oct 9Officer or director changeOct 6open on EDGAR ↗
Sep 16Officer or director changeReg FD disclosureSep 15open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch MYGN. Know when insiders buy.
One email the day a filing lands. Free.